Toronto Dominion Bank Vertex Pharmaceuticals Inc Transaction History

Toronto Dominion Bank

  • $55.7 Billion
  • Q3 2024

A detailed history of Toronto Dominion Bank transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Toronto Dominion Bank holds 134,202 shares of VRTX stock, worth $60.6 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
134,202
Previous 134,202 -0.0%
Holding current value
$60.6 Million
Previous $62.4 Million -0.0%
% of portfolio
0.11%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$460.0 - $505.78 $1.42 Million - $1.57 Million
3,096 Added 2.36%
134,202 $62.4 Million
Q2 2024

Aug 14, 2024
SELL
$392.81 - $485.53 $8.58 Million - $10.6 Million
-21,853 Reduced 14.29%
131,106 $61.5 Million
Q1 2024

May 14, 2024
BUY
$407.69 - $446.08 $1.2 Million - $1.32 Million
2,950 Added 1.97%
152,959 $63.9 Million
Q4 2023

Feb 13, 2024
BUY
$343.0 - $410.68 $4.73 Million - $5.67 Million
13,796 Added 10.13%
150,009 $61 Million
Q3 2023

Feb 14, 2024
SELL
$338.18 - $362.46 $1.27 Million - $1.36 Million
-3,742 Reduced 2.67%
136,213 $47.4 Million
Q3 2023

Nov 14, 2023
SELL
$338.18 - $362.46 $1.27 Million - $1.36 Million
-3,742 Reduced 2.67%
136,213 $47.4 Million
Q2 2023

Feb 14, 2024
SELL
$314.42 - $351.91 $3.16 Million - $3.54 Million
-10,054 Reduced 6.7%
139,955 $49.2 Million
Q2 2023

Aug 10, 2023
BUY
$314.42 - $351.91 $3.41 Million - $3.82 Million
10,851 Added 8.4%
139,955 $49.2 Million
Q1 2023

May 11, 2023
SELL
$283.23 - $323.1 $2.05 Million - $2.33 Million
-7,226 Reduced 5.3%
129,104 $40.7 Million
Q4 2022

Feb 07, 2023
BUY
$285.76 - $321.48 $5.77 Million - $6.49 Million
20,190 Added 17.38%
136,330 $39.3 Million
Q3 2022

Nov 09, 2022
SELL
$273.83 - $305.53 $2.69 Million - $3 Million
-9,809 Reduced 7.79%
116,140 $33.6 Million
Q2 2022

Aug 11, 2022
SELL
$234.96 - $292.55 $1.23 Million - $1.53 Million
-5,223 Reduced 3.98%
125,949 $35.5 Million
Q1 2022

May 09, 2022
SELL
$221.42 - $260.97 $5.34 Million - $6.29 Million
-24,109 Reduced 15.53%
131,172 $34.2 Million
Q4 2021

Feb 04, 2022
SELL
$177.01 - $223.45 $12.3 Million - $15.5 Million
-69,234 Reduced 30.84%
155,281 $34.1 Million
Q3 2021

Nov 08, 2021
BUY
$181.39 - $202.99 $5.91 Million - $6.61 Million
32,565 Added 16.97%
224,515 $40.7 Million
Q2 2021

Aug 13, 2021
BUY
$187.49 - $221.1 $36 Million - $42.4 Million
191,950 New
191,950 $38.7 Million

Others Institutions Holding VRTX

# of Institutions
1,721
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email